To monitor adverse effects related to the statin therapy, plasma glucose, aspartate aminotransferase, alanine aminotransferase, creatinine, and creatine kinase levels were assessed at 6 weeks and 12, 24, and 36 months. Hemoglobin A1c was assessed at 12, 24, and 36 months. Study End Point T...
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization of pharmaceutical products. All statements that are not statements of historical facts are,...
patients who received KEYTRUDA as a single agent, given as adjuvant treatment; the most frequent adverse reactions (≥1%) that led to permanent discontinuation of KEYTRUDA were diarrhea (1.7%), interstitial lung disease (1.4%), increased...
patients who received KEYTRUDA as a single agent, given as adjuvant treatment; the most frequent adverse reactions (≥1%) that led to permanent discontinuation of KEYTRUDA were diarrhea (1.7%), interstitial lung disease ...
After that, the activities of the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and the levels of the serum triglyceride (TG), Cholesterol (Ch), high-density lipoprotein-Cholesterol (HDL-C) and liver TG were evaluated. Results: Compared with group A, the activities...
AST ( Aspartate aminotransferase) 160 U/L ALT (Alanine aminotransferase) 190 U/L Which of the following is most helpful in establishing the diagnosis A. Serum Ferritin B. Serum Ceruloplasmin leve C. Anti-Actin and Smooth muscle antibodies D. 2D Echocardiogram E. Serum Alpha-1 anti-trypsin lev...
Merck announced that the pivotal Phase 3 KEYNOTE-756 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met one of its dual primary endpoints of pathological complete respons...
To monitor adverse effects related to the statin therapy, plasma glucose, aspartate aminotransferase, alanine aminotransferase, creatinine, and creatine kinase levels were assessed at 6 weeks and 12, 24, and 36 months. Hemoglobin A1c was assessed at 12, 24, and 36 months. Study End Point ...
patients who received KEYTRUDA as a single agent, given as adjuvant treatment; the most frequent adverse reactions (≥1%) that led to permanent discontinuation of KEYTRUDA were diarrhea (1.7%), interstitial lung disease (1...
patients who received KEYTRUDA as a single agent, given as adjuvant treatment; the most frequent adverse reactions (≥1%) that led to permanent discontinuation of KEYTRUDA were diarrhea (1.7%), interstitial lung d...